Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
出版年份 2021 全文链接
标题
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
作者
关键词
FPR2/ALX, Agonists, Resolution, Inflammation
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 213, Issue -, Pages 113167
出版商
Elsevier BV
发表日期
2021-01-13
DOI
10.1016/j.ejmech.2021.113167
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation
- (2020) Simon McArthur et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
- (2020) Youwen Zhuang et al. Nature Communications
- Structural basis of ligand binding modes at the human formyl peptide receptor 2
- (2020) Tong Chen et al. Nature Communications
- Dual modulation of formyl peptide receptor 2 by aspirin‐triggered lipoxin contributes to its anti‐inflammatory activity
- (2020) Yunjun Ge et al. FASEB JOURNAL
- Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
- (2020) Yoshikazu Asahina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Balancing the Effect of Leukotrienes in Asthma
- (2020) Catherine Godson NEW ENGLAND JOURNAL OF MEDICINE
- Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis
- (2020) Letizia Crocetti et al. BIOORGANIC CHEMISTRY
- Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
- (2020) Mauro Perretti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
- (2019) Xiaofang Chen et al. DIABETES
- The n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family
- (2019) Gaetan Drouin et al. BIOCHIMIE
- ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
- (2019) Simona Gallo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Substituted Pyridazin-3(2H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
- (2019) Girdhar Singh Deora et al. JOURNAL OF MEDICINAL CHEMISTRY
- Annexin-A1: Therapeutic Potential in Microvascular Disease
- (2019) Gareth S. D. Purvis et al. Frontiers in Immunology
- Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure
- (2019) Vasundhara Kain et al. PHARMACOLOGICAL RESEARCH
- Targeting formyl peptide receptors to facilitate the resolution of inflammation
- (2018) János G. Filep et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardioprotective signalling: Past, present and future
- (2018) Aleksandar Jovanović EUROPEAN JOURNAL OF PHARMACOLOGY
- Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis
- (2018) Dragana Odobasic et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Neutrophils: Beneficial and Harmful Cells in Septic Arthritis
- (2018) Daiane Boff et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes
- (2018) Subodh Verma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases
- (2018) Nandini Krishnamoorthy et al. PHYSIOLOGICAL REVIEWS
- Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
- (2018) Agostino Cilibrizzi Nature Communications
- Correspondence: Reply to ‘Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury’
- (2018) Cheng Xue Qin et al. Nature Communications
- Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
- (2018) E. P. Brennan et al. DIABETES
- Mimetic peptide AC2-26 of annexin A1 as a potential therapeutic agent to treat COPD
- (2018) Lucas Possebon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
- (2018) Réginald Philippe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of signalling and biased agonism in G protein-coupled receptors
- (2018) Denise Wootten et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Formyl-Peptide Receptors in Infection, Inflammation, and Cancer
- (2018) Elisabeth Weiß et al. TRENDS IN IMMUNOLOGY
- Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
- (2018) Monica de Gaetano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- (Re) Solving Repair After Myocardial Infarction
- (2018) Giovanna Leoni et al. Frontiers in Pharmacology
- Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
- (2018) Monica de Gaetano et al. Frontiers in Pharmacology
- Biased perspectives on formyl peptide receptors
- (2018) Carsten Alexander Raabe et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Novel ureidopropanamide based N -formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
- (2017) Madia Letizia Stama et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Specialized pro-resolving mediators in renal fibrosis
- (2017) Eoin P. Brennan et al. MOLECULAR ASPECTS OF MEDICINE
- New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
- (2017) Charles N. Serhan et al. MOLECULAR ASPECTS OF MEDICINE
- The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
- (2017) Hui-Qiong He et al. MOLECULES
- Immune resolution mechanisms in inflammatory arthritis
- (2017) Mauro Perretti et al. Nature Reviews Rheumatology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The novel lipid mediator PD1 n-3 DPA : An overview of the structural elucidation, synthesis, biosynthesis and bioactions
- (2017) Trond Vidar Hansen et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
- (2017) Xia Kong et al. Experimental and Therapeutic Medicine
- Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
- (2017) Cheng Xue Qin et al. Nature Communications
- FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
- (2017) Xi-Lu Hou et al. Scientific Reports
- 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists
- (2016) Claudia Vergelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949
- (2016) Anna K. Stalder et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology
- (2016) Brian E. Sansbury et al. CIRCULATION RESEARCH
- Synthesis of Five- and Six-MemberedN-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists
- (2016) Claudia Vergelli et al. DRUG DEVELOPMENT RESEARCH
- Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study
- (2016) Enza Lacivita et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
- (2016) Melody G. Duvall et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
- (2016) Benedict Wu et al. FASEB JOURNAL
- Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
- (2016) Alessandra Cadete Martini et al. Journal of Neuroinflammation
- Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion
- (2016) R R Hodges et al. Mucosal Immunology
- Structure-based discovery of opioid analgesics with reduced side effects
- (2016) Aashish Manglik et al. NATURE
- Inflammatory processes in cardiovascular disease: a route to targeted therapies
- (2016) Neil Ruparelia et al. Nature Reviews Cardiology
- Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells
- (2016) Soon Chul Heo et al. STEM CELLS
- Resolution of Inflammation: What Controls Its Onset?
- (2016) Michelle A. Sugimoto et al. Frontiers in Immunology
- Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
- (2015) Sarah K. Orr et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
- (2015) Emma Börgeson et al. Cell Metabolism
- Structural insights into µ-opioid receptor activation
- (2015) Weijiao Huang et al. NATURE
- Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
- (2015) Mauro Perretti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis
- (2014) W Kao et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
- (2014) Marcelo H. Petri et al. CARDIOVASCULAR RESEARCH
- Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
- (2014) F. C. Ringholz et al. EUROPEAN RESPIRATORY JOURNAL
- Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury
- (2014) Huifang Tang et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Maresin-1 Engages Regulatory T Cells To Limit Type 2 Innate Lymphoid Cell Activation and Promote Resolution of Lung Inflammation
- (2014) Nandini Krishnamoorthy et al. JOURNAL OF IMMUNOLOGY
- FPR2/ALXR Agonists and the Resolution of Inflammation
- (2014) Olivier Corminboeuf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
- (2014) Thomas Gobbetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists
- (2013) Maria Paola Giovannoni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands
- (2013) Hui-Qiong He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGF R1
- (2013) E. P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
- (2013) S. N. Cooray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
- (2013) C. Barnig et al. Science Translational Medicine
- Novel n-3 Immunoresolvents: Structures and Actions
- (2013) Jesmond Dalli et al. Scientific Reports
- 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: Molecular modeling of chiral recognition by FPR2
- (2012) Igor A. Schepetkin et al. BIOCHEMICAL PHARMACOLOGY
- Efficacy and safety of 15(R/S)-methyl-lipoxin A4in topical treatment of infantile eczema
- (2012) S.-H. Wu et al. BRITISH JOURNAL OF DERMATOLOGY
- Cell Surface Receptor FPR2 Promotes Antitumor Host Defense by Limiting M2 Polarization of Macrophages
- (2012) Y. Liu et al. CANCER RESEARCH
- Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system
- (2012) Felicity N. E. Gavins et al. FASEB JOURNAL
- Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
- (2012) S. Ramon et al. JOURNAL OF IMMUNOLOGY
- Resolvin E2 Formation and Impact in Inflammation Resolution
- (2012) S. F. Oh et al. JOURNAL OF IMMUNOLOGY
- Molecular Circuits of Resolution in Renal Disease
- (2011) Emma Börgeson et al. TheScientificWorldJOURNAL
- FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
- (2010) Paola Maderna et al. FASEB JOURNAL
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?
- (2010) Felicity N.E. Gavins TRENDS IN PHARMACOLOGICAL SCIENCES
- Lipoxins: resolutionary road
- (2009) Paola Maderna et al. BRITISH JOURNAL OF PHARMACOLOGY
- Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
- (2009) N. Baker et al. JOURNAL OF IMMUNOLOGY
- 6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide Receptors
- (2009) Agostino Cilibrizzi et al. JOURNAL OF MEDICINAL CHEMISTRY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
- Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs
- (2009) Yee-Ping Sun et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
- (2008) Nicos A. Petasis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genetic Variation in Members of the Leukotriene Biosynthesis Pathway Confer an Increased Risk of Ischemic Stroke
- (2008) Steve Bevan et al. STROKE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started